{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:20:43Z","timestamp":1783110043017,"version":"3.54.6"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T00:00:00Z","timestamp":1501027200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0181723","type":"journal-article","created":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T13:33:02Z","timestamp":1501075982000},"page":"e0181723","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Gelatin nanoparticles enhance delivery of hepatitis C virus recombinant NS2 gene"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4097-7866","authenticated-orcid":true,"given":"Salwa","family":"Sabet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina A.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidan M.","family":"El-Shorbagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"Bassiony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled Y.","family":"Farroh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tareq","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taher A.","family":"Salaheldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,7,26]]},"reference":[{"issue":"7","key":"ref1","doi-asserted-by":"crossref","first-page":"587","DOI":"10.26719\/2013.19.7.587","article-title":"Hepatitis C in the Eastern Mediterranean Region","volume":"19","author":"G Esmat","year":"2013","journal-title":"East Mediterr Health J"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/jmv.21492","article-title":"Genetic variability of hepatitis C virus in South Egypt and its possible clinical implication","volume":"81","author":"A Elkady","year":"2009","journal-title":"J Med Virol"},{"issue":"17","key":"ref3","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.3748\/wjg.v13.i17.2436","article-title":"Epidemiology of hepatitis C virus infection","volume":"13","author":"MJ Alter","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"7","key":"ref4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00535-007-2064-6","article-title":"The epidemiology of hepatitis C infection in the United States","volume":"42","author":"VK Rustgi","year":"2007","journal-title":"J Gastroenterol"},{"key":"ref5","article-title":"Should surveillance for liver cancer be modified in hepatitis c patients after treatment-related cirrhosis regression?","author":"R D'Ambrosio","year":"2016","journal-title":"Liver Int"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1136\/gut.2004.057182","article-title":"Peginterferon {alpha}-2b and ribavirin therapy in chronic hepatitis C genotype 4: impact of treatment duration and viral kinetics on sustained virological response","volume":"54","author":"SM Kamal","year":"2005","journal-title":"Gut"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2334-7-8","article-title":"Adult systemic cat scratch disease associated with therapy for hepatitis C","volume":"7","author":"Z Bhatti","year":"2007","journal-title":"BMC Infect Dis"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2893.2006.00795.x","article-title":"Does the clinical outcome of hepatitis C infection vary with the infecting hepatitis C virus type?","volume":"14","author":"HE Harris","year":"2007","journal-title":"J Viral Hepat"},{"issue":"8","key":"ref9","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/j.1478-3231.2008.01750.x","article-title":"Predictors of a sustained virological response in patients with genotype 4 chronic hepatitis C","volume":"28","author":"RR Gad","year":"2008","journal-title":"Liver Int"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jhep.2015.04.023","article-title":"Sofosbuvir plus ribavirin for treating Egyptian patients with hepatitis C genotype 4","volume":"63","author":"W Doss","year":"2015","journal-title":"J Hepatol"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/hep.510310332","article-title":"The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States","volume":"31","author":"GL Armstrong","year":"2000","journal-title":"Hepatology"},{"issue":"1","key":"ref12","first-page":"1","article-title":"Immunogenicity evaluation of a DNA vaccine expressing the hepatitis C virus non-structural protein 2 gene in C57BL\/6 mice","volume":"18","author":"Z Gorzin","year":"2014","journal-title":"Iran Biomed J"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1006\/viro.2002.1701","article-title":"Hepatitis C virus NS2 protein inhibits gene expression from different cellular and viral promoters in hepatic and nonhepatic cell lines","volume":"305","author":"FL Dumoulin","year":"2003","journal-title":"Virology"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"e1001233","DOI":"10.1371\/journal.ppat.1001233","article-title":"Structural and functional studies of nonstructural protein 2 of the hepatitis C virus reveal its key role as organizer of virion assembly","volume":"6","author":"V Jirasko","year":"2010","journal-title":"PLoS Pathog"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"e1001278","DOI":"10.1371\/journal.ppat.1001278","article-title":"NS2 protein of hepatitis C virus interacts with structural and non-structural proteins towards virus assembly","volume":"7","author":"C-I Popescu","year":"2011","journal-title":"PLoS Pathog"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2893.2011.01504.x","article-title":"Identification of residues involved in NS2 homodimerization and elucidation of their impact on the HCV life cycle","volume":"19","author":"AA Gorzin","year":"2012","journal-title":"J Viral Hepat"},{"issue":"8","key":"ref17","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.3390\/v2081635","article-title":"The Hepatitis C Virus Nonstructural Protein 2 (NS2): An Up-and-Coming Antiviral Drug Target","volume":"2","author":"IC Lorenz","year":"2010","journal-title":"Viruses"},{"issue":"5","key":"ref18","first-page":"962","article-title":"In vitro and in vivo targeting of gene expression to melanoma cells","volume":"53","author":"RG Vile","year":"1993","journal-title":"Cancer Res"},{"issue":"4949 Pt 1","key":"ref19","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1690918","article-title":"Direct gene transfer into mouse muscle in vivo","volume":"247","author":"JA Wolff","year":"1990","journal-title":"Science"},{"key":"ref20","first-page":"3","article-title":"The mechanism of naked DNA uptake and expression","volume":"54","author":"JA Wolff","year":"2005","journal-title":"Adv Genet"},{"issue":"6753","key":"ref21","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/43977","article-title":"Virus treatment questioned after gene therapy death","volume":"401","author":"S Lehrman","year":"1999","journal-title":"Nature"},{"issue":"11","key":"ref22","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/sj.gt.3302039","article-title":"Immune responses to adeno-associated virus and its recombinant vectors","volume":"10","author":"JY Sun","year":"2003","journal-title":"Gene Ther"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13273-014-0001-3","article-title":"Nanoparticles for gene delivery: therapeutic and toxic effects","volume":"10","author":"YS Choi","year":"2014","journal-title":"Mol Cell Toxicol"},{"issue":"1\u20133","key":"ref24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jconrel.2005.09.023","article-title":"Gelatin as a delivery vehicle for the controlled release of bioactive molecules","volume":"109","author":"S Young","year":"2005","journal-title":"Journal of Controlled Release"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2010.04.008","article-title":"Matrix-loaded biodegradable gelatin nanoparticles as new approach to improve drug loading and delivery","volume":"76","author":"K Ofokansi","year":"2010","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/026520400288427","article-title":"Gelatin nanoparticles by two step desolvation\u2014a new preparation method, surface modifications and cell uptake","volume":"17","author":"CJ Coester","year":"2000","journal-title":"J Microencapsul"},{"key":"ref27","first-page":"Unit-15.1","article-title":"Enzymatic amplification of DNA by PCR: standard procedures and optimization","volume":"Chapter 15","author":"MF Kramer","year":"2001","journal-title":"Curr Protoc Mol Biol"},{"issue":"9","key":"ref28","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1517\/17425247.2015.1037272","article-title":"Drug delivery from gelatin-based systems","volume":"12","author":"M Foox","year":"2015","journal-title":"Expert Opin Drug Deliv"},{"issue":"11","key":"ref29","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1007\/s10529-015-1907-0","article-title":"Recent advances in the use of gelatin in biomedical research","volume":"37","author":"K Su","year":"2015","journal-title":"Biotechnol Lett"},{"key":"ref30","article-title":"Dry powder form of polymeric nanoparticles for pulmonary drug delivery","author":"F Shiehzadeh","year":"2016","journal-title":"Curr Pharm Des"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.bbrc.2004.04.067","article-title":"Incorporation of biodegradable nanoparticles into human airway epithelium cells-in vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseases","volume":"318","author":"M Brzoska","year":"2004","journal-title":"Biochemical and biophysical research communications"},{"issue":"12","key":"ref32","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1080\/02664760802382426","article-title":"Optimization of parameters for the fabrication of gelatin nanoparticles by the Taguchi robust design method","volume":"35","author":"M Jahanshahi","year":"2008","journal-title":"Journal of Applied Statistics"},{"issue":"12","key":"ref33","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1002\/pssa.200824329","article-title":"Gelatin nanoparticle fabrication and optimization of the particle size","volume":"205","author":"M Jahanshahi","year":"2008","journal-title":"physica status solidi (a)"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/238351","article-title":"Cationic Gelatin Nanoparticles for Drug Delivery to the Ocular Surface:In VitroandIn VivoEvaluation","volume":"2013","author":"C-L Tseng","year":"2013","journal-title":"Journal of Nanomaterials"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s11095-007-9410-5","article-title":"Delivery by cationic gelatin nanoparticles strongly increases the immunostimulatory effects of CpG oligonucleotides","volume":"25","author":"K Zwiorek","year":"2008","journal-title":"Pharmaceutical research"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4103\/2230-973X.119213","article-title":"Development and characterization of gelatin based nanoparticles for targeted delivery of zidovudine","volume":"3","author":"NR Jadhav","year":"2013","journal-title":"International journal of pharmaceutical investigation"},{"issue":"12","key":"ref37","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1089\/hum.1998.9.12-1709","article-title":"Controlled gene delivery by DNA-gelatin nanospheres","volume":"9","author":"VL Truong-Le","year":"1998","journal-title":"Hum Gene Ther"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/pat.3432","article-title":"Polymers in gene therapy technology","volume":"26","author":"H Hosseinkhani","year":"2015","journal-title":"Polymers for Advanced Technologies"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0181723","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T13:03:34Z","timestamp":1569935014000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0181723"}},"subtitle":[],"editor":[{"given":"Abhijit","family":"De","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,7,26]]},"references-count":38,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0181723","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,26]]}}}